Cargando…
CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
INTRODUCTION: Dysregulation of cell cycle progression (CCP) is a trait that distinguishes cancer from other diseases. In several cancer types, CCP-related genes serve as the primary risk factor for prognosis, but their role in cutaneous melanoma remains unclear. METHODS: Data from cutaneous melanoma...
Autores principales: | Li, Tianhao, Wang, Liquan, Yu, Nanze, Zeng, Ang, Huang, Jiuzuo, Long, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876620/ https://www.ncbi.nlm.nih.gov/pubmed/36713580 http://dx.doi.org/10.3389/fonc.2022.1055308 |
Ejemplares similares
-
Prognostic biomarker CCR6 and its correlation with immune infiltration in cutaneous melanoma
por: Nurzat, Yeltai, et al.
Publicado: (2023) -
ITGAL as a prognostic biomarker correlated with immune infiltrates in melanoma
por: Deng, TengFei, et al.
Publicado: (2023) -
CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Wang, Zhihuai, et al.
Publicado: (2021) -
DIRAS2 Is a Prognostic Biomarker and Linked With Immune Infiltrates in Melanoma
por: Xue, Wenli, et al.
Publicado: (2022) -
Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma
por: Tang, Diana Y. L., et al.
Publicado: (2016)